Back to Search Start Over

BioMarin creates new-look R&D and deal teams with Roche's Sabry, Amgen's Friberg.

Authors :
Taylor, Nick Paul
Source :
FierceBiotech; 8/21/2024, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

BioMarin is shaking up its leadership team, raiding Amgen for an R&D chief and pulling off the coup of signing a high-profile former Roche dealmaker. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
COUPS d'etat

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
179176740

Tools

Authors Abstract Subjects Details